$SYM

KANE CHARLES sold $92K of SYM

KANE CHARLES sold 2,000 shares of Symbotic Inc. (SYM) at $45.99 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · KANE CHARLES
Published Jun 3, 2026, 11:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SYM
Neutral
medium confidence
Mentioned
$SYM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SYMNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but is typically discounted when tied to 10b5-1 plans; absent other news, it is unlikely to drive a durable repricing.

02

Market read

A routine 10b5-1 director sale in SYM, with limited expected impact unless part of a broader pattern.

03

What to watch

Traders may over-weight the sale; the key is whether there are repeated, non-10b5-1 sales or concurrent fundamental disclosures (not present here).

Relevance 6/10Novelty 3/10Timing: Filed 2026-06-03; sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure (director selling shares) for Symbotic, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$SYMNeutralMedium confidence
Context

Director Kane Charles sold 2,000 Symbotic shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Limited/short-lived impact; any reaction likely fades unless accompanied by other fundamental news.

Evidence & confidence

The filing is a routine 10b5-1 sale by a director, with no accompanying operational or financial catalyst stated in the article.

Market effects

Minimal; this is company-specific insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than a negative view on fundamentals.

Key entities

  • Symbotic Inc.

    Public company whose director executed an open-market sale disclosed on Form 4.

  • Kane Charles

    Director who sold 2,000 shares; transaction is marked as under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SYMHigh

A sorter steers goods in any direction, replacing traditional conveyor systems

Symbotic Inc. (SYM) acquired cellumation GmbH, a German automation company, for its celluveyor technology. The celluveyor is a software-driven sortation platform that replaces traditional conveyors, offering greater density, throughput, and efficiency. Symbotic aims to integrate the technology into its systems and expand its European presence. cellumation will continue operating independently, serving its global customer base.

$SYMMed

Symbotic director Charles Kane sells $78,000 of Class A stock

Symbotic Inc. director Charles Kane sold 2,000 shares of Class A stock for $78,000 at $39 per share on September 1, 2026. The stock currently trades at $41.60, down 30% year-to-date. Symbotic reported Q3 revenue of $721 million, up 22% YoY, and adjusted EBITDA of $95 million, more than double the previous year. Despite strong results, the stock declined in after-hours trading due to concerns over future margins and outlook.

$NBISMed

3 Growth Stocks to Buy Before Wall Street Catches On

Nebius (NBIS) reported 454% revenue growth and a $37.5B backlog, with Meta and NVIDIA deals. Symbotic (SYM) trades near 52-week lows despite a $22.5B backlog. Centrus Energy (LEU) beat Q2 EPS by 93% with a $4.5B backlog. All three companies show high growth but trade below consensus targets.

$SYMMed

What’s Really Behind Symbotic’s (SYM) Big Quarter?

Symbotic Inc. (NASDAQ:SYM) reported fiscal Q3 revenue of $721M, up 22% year over year, with net income of $55M versus a $21M loss a year earlier. Adjusted EBITDA rose to $95M. The company said 11 new deployments brought totals to 77 in deployment. Shares face a high forward P/E (238.1) and 28.1% short interest.